<div>
	They are: Trastuzumab, prescribed for treatment of early-stage breast cancer; Nilotinib, prescribed for the treatment of chronic myeloid leukemia; Dasatinib, prescribed for treatment of chronic myeloid leukemia that resists Imatinib and Nilotinib; and Peg-Interferon prescribed for the treatment of hepatitis.&nbsp;</div>
<div>
	&nbsp;</div>

NHSO agrees to 4 'pricey' medicines

Strong AI demand lifts Japan’s core machinery orders by 5.2%

Japan to provide financial support for New York semiconductor plant

Jarupong is a reporter and translator specialising in technology and sustainability.

jarupong_kri@nationgroup.com

IMF–World Bank talks highlight AI opportunities and fiscal risks

Queen Sirikit MRT station to close for 7 hours on October 16

Nongluck is a senior economic journalist covering the macroeconomics, real estate, and corporate investment strategies driving growth across Thailand and Southeast Asia.

NHSO agrees to 4 'pricey' medicines

The National Health Security Office (NHSO) board recently approved the universal health scheme's coverage of four extra medicines, which were necessary but rather expensive, NHSO deputy chief Netnapis Suchonwanich said Monday.

'Speeding' motorcycle rider plunges 6 metres down hole on Thonburi road

Military trucks on standby at 11 Bangkok districts to transport commuters

Constitutional Court chief orders probe into ‘leak’ of witness’ statement